Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Registration - In-house Organization

Psychedelics Canada—The Canada Psychedelic Businesses Association / Liam Bedard, Coordinator

Registration Information

In-house Organization name: Psychedelics Canada—The Canada Psychedelic Businesses Association
Responsible Officer Name: Liam Bedard, Coordinator 
Initial registration start date: 2022-07-01
Registration status: Active
Registration Number: 952635-372370

Associated Communications

Total Number of Communication Reports: 23

Monthly communication reports in the last 6 months: 1

Version 2 of 2 (2024-05-08 to present)

Version 2 of 2 (2024-05-08 to present)



Responsible Officer Name

This is the responsible officer name as provided in the most recent registration for the corporation or organization.

Name Change History:

Psychedelics Canada—The Canada Psychedelic Businesses Association/

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name From To
Psychedelics Canada—The Canada Psychedelic Businesses Association/ 2024-05-08 current
Psychedelics Canada—The Canada Psychedelic Businesses Association/ 2022-07-01 2024-05-08

Responsible Officer Change History

Psychedelics Canada—The Canada Psychedelic Businesses Association

Responsible Officer History
Responsible Officer Name From (YYYY-MM-DD) To (YYYY-MM-DD)

All Monthly Communication Reports for Psychedelics Canada—The Canada Psychedelic Businesses Association

Liam Bedard, Coordinator (Organization)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-23 of 23

  • Psychedelics Canada—The Canada Psychedelic Businesses Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Cesare Spadaccini, Manager,Operational Policy | OFFICE OF CONTROLLED SUBSTANCES | Health Canada (HC)
    • Karen Reynolds, Director General | PHARMACEUTICAL DRUGS DIRECTORATE | Health Canada (HC)
    • Rita Beregszaszy, Director | Bureau of Policy, Science, and International Programs | Health Canada (HC)
    • Kathy Soltys, Director, Office of Clinical Trials | Pharmaceutical Drug Directorate | Health Canada (HC)
    • Jennifer Pelley, Director | Office of Legislative and Regulatory Affairs | Health Canada (HC)

    Subject Matter of the communication: Health, Justice and Law Enforcement, Science and Technology, International Trade
    Communication date: 2024-04-30
    Posted date: 2024-05-08
    Communication number: 372370-602195 View associated registration
  • Psychedelics Canada—The Canada Psychedelic Businesses Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Julia Duncan, Senior Policy Advisor | Office of the Minister of Mental Health and Addictions | Health Canada (HC)
    • Eshan Naik, Director of Policy | Office of the Leader of the Government in the House of Commons | House of Commons

    Subject Matter of the communication: Health, Justice and Law Enforcement, Science and Technology
    Communication date: 2023-11-28
    Posted date: 2023-12-11
    Communication number: 372370-586315 View associated registration
  • Psychedelics Canada—The Canada Psychedelic Businesses Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Charles Sousa, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Justice and Law Enforcement, Science and Technology
    Communication date: 2023-11-07
    Posted date: 2023-12-11
    Communication number: 372370-586308 View associated registration
  • Psychedelics Canada—The Canada Psychedelic Businesses Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Nathaniel Erksine-Smith, Member of Parliament | House of Commons
    • Luc Thériault, Member of Parliament | House of Commons
    • Corey Tochor, Member of Parliament | House of Commons
    • Marcus Powlowski, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Justice and Law Enforcement, Science and Technology
    Communication date: 2023-10-31
    Posted date: 2023-12-11
    Communication number: 372370-586310 View associated registration
  • Psychedelics Canada—The Canada Psychedelic Businesses Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Majid Jowhari, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Justice and Law Enforcement, Science and Technology
    Communication date: 2023-10-31
    Posted date: 2023-12-11
    Communication number: 372370-586303 View associated registration
  • Psychedelics Canada—The Canada Psychedelic Businesses Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jenica Atwin, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Justice and Law Enforcement, Science and Technology
    Communication date: 2023-10-30
    Posted date: 2023-12-11
    Communication number: 372370-586314 View associated registration
  • Psychedelics Canada—The Canada Psychedelic Businesses Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Anton Lori, Satekholder Relations Advisor | Office of the Leader of the Official Opposition | House of Commons

    Subject Matter of the communication: Health, Justice and Law Enforcement, Science and Technology
    Communication date: 2023-10-30
    Posted date: 2023-12-11
    Communication number: 372370-586309 View associated registration
  • Psychedelics Canada—The Canada Psychedelic Businesses Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Carol Anne Chénard, Director | Office of Controlled Substances | Health Canada (HC)
    • Daniel Keene, Associate Director | Office of Clinical Trials | Health Canada (HC)
    • Kathy Soltys, Director | Office of Clinical Trials | Health Canada (HC)
    • Jennifer Pelley, Director | Office of Legislative and Regulatory Affairs | Health Canada (HC)

    Subject Matter of the communication: Health, Justice and Law Enforcement, Science and Technology
    Communication date: 2023-06-13
    Posted date: 2023-07-27
    Communication number: 372370-573547 View associated registration
  • Psychedelics Canada—The Canada Psychedelic Businesses Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jamie Kippen, Chief of Staff to the Minister | Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health, Justice and Law Enforcement, Science and Technology
    Communication date: 2023-03-01
    Posted date: 2023-04-15
    Communication number: 372370-557572 View associated registration
  • Psychedelics Canada—The Canada Psychedelic Businesses Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Carolyn Bennett, Minister of Mental Health and Addictions and Associate Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health, Justice and Law Enforcement, Science and Technology
    Communication date: 2022-11-03
    Posted date: 2022-12-15
    Communication number: 372370-545194 View associated registration
  • Psychedelics Canada—The Canada Psychedelic Businesses Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jenica Atwin, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Justice and Law Enforcement, Science and Technology
    Communication date: 2022-10-12
    Posted date: 2022-11-15
    Communication number: 372370-543316 View associated registration
  • Psychedelics Canada—The Canada Psychedelic Businesses Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Laurel Collins, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Justice and Law Enforcement, Science and Technology
    Communication date: 2022-10-11
    Posted date: 2022-11-15
    Communication number: 372370-542977 View associated registration
  • Psychedelics Canada—The Canada Psychedelic Businesses Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gord Johns, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Justice and Law Enforcement, Science and Technology
    Communication date: 2022-10-06
    Posted date: 2022-10-11
    Communication number: 372370-542973 (amended from 372370-542969) View associated registration
  • Psychedelics Canada—The Canada Psychedelic Businesses Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rebecca Caldwell, Senior Policy Advisor | Senior Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Justice and Law Enforcement, Science and Technology
    Communication date: 2022-10-06
    Posted date: 2022-11-15
    Communication number: 372370-542971 View associated registration
  • Psychedelics Canada—The Canada Psychedelic Businesses Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Anushua Nag, Policy Advisor | Justice Canada (JC)

    Subject Matter of the communication: Health, Justice and Law Enforcement, Science and Technology
    Communication date: 2022-10-06
    Posted date: 2022-11-15
    Communication number: 372370-542970 View associated registration
  • Psychedelics Canada—The Canada Psychedelic Businesses Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Corey Tochor, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Justice and Law Enforcement, Science and Technology
    Communication date: 2022-10-05
    Posted date: 2022-11-15
    Communication number: 372370-542660 View associated registration
  • Psychedelics Canada—The Canada Psychedelic Businesses Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Nathaniel Erskine-Smith, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Justice and Law Enforcement, Science and Technology
    Communication date: 2022-10-05
    Posted date: 2022-11-15
    Communication number: 372370-542659 View associated registration
  • Psychedelics Canada—The Canada Psychedelic Businesses Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Elizabeth May, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Justice and Law Enforcement, Science and Technology
    Communication date: 2022-10-05
    Posted date: 2022-11-15
    Communication number: 372370-542658 View associated registration
  • Psychedelics Canada—The Canada Psychedelic Businesses Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jaigi Mathai, Senior Evaluator | Office of Clinical Trials | Health Canada (HC)
    • Daniel Keene, Associate Director | Office of Clinical Trials | Health Canada (HC)
    • Kathy Soltys, Director | Office of Clinical Trials | Health Canada (HC)
    • Graeme Simpson, Senior Policy Analyst | Office of Controlled Substances | Health Canada (HC)
    • Jenny-Lee Choon, Acting Manager | Office of Controlled Substances | Health Canada (HC)
    • Cesare Spadaccini, Manager | Office of Controlled Substances | Health Canada (HC)
    • Marc-André Roy, Associate Director | Office of Controlled Substances | Health Canada (HC)
    • Sarah Schlegelmilch, Senior Policy Analyst | Office of Legislative and Regulatory Affairs | Health Canada (HC)
    • Kristen Beausoleil, Manager | Office of Legislative and Regulatory Affairs | Health Canada (HC)
    • Jennifer Saxe, Director General | Controlled Substances Directorate, Controlled Substances and Cannabis Branch | Health Canada (HC)
    • Jennifer Pelley, Director | Office of Legislative and Regulatory Affairs | Health Canada (HC)

    Subject Matter of the communication: Health, Justice and Law Enforcement, Science and Technology
    Communication date: 2022-10-04
    Posted date: 2022-11-15
    Communication number: 372370-542975 View associated registration
  • Psychedelics Canada—The Canada Psychedelic Businesses Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Randeep Sarai, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Justice and Law Enforcement, Science and Technology
    Communication date: 2022-10-04
    Posted date: 2022-11-15
    Communication number: 372370-542628 View associated registration
  • Psychedelics Canada—The Canada Psychedelic Businesses Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Richard Cannings, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Justice and Law Enforcement, Science and Technology
    Communication date: 2022-10-03
    Posted date: 2022-11-15
    Communication number: 372370-542627 View associated registration
  • Psychedelics Canada—The Canada Psychedelic Businesses Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alistair MacGregor, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Justice and Law Enforcement, Science and Technology
    Communication date: 2022-10-03
    Posted date: 2022-11-15
    Communication number: 372370-542556 View associated registration
  • Psychedelics Canada—The Canada Psychedelic Businesses Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Cyd Courchesne, Chief Medical Officer | Veterans Affairs Canada (VAC)

    Subject Matter of the communication: Health, Science and Technology
    Communication date: 2022-09-29
    Posted date: 2022-10-15
    Communication number: 372370-542347 View associated registration

Monthly Communication Reports in the last 6 Months for Psychedelics Canada—The Canada Psychedelic Businesses Association

Liam Bedard, Coordinator (Organization)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-23 of 23

  • Psychedelics Canada—The Canada Psychedelic Businesses Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Cesare Spadaccini, Manager,Operational Policy | OFFICE OF CONTROLLED SUBSTANCES | Health Canada (HC)
    • Karen Reynolds, Director General | PHARMACEUTICAL DRUGS DIRECTORATE | Health Canada (HC)
    • Rita Beregszaszy, Director | Bureau of Policy, Science, and International Programs | Health Canada (HC)
    • Kathy Soltys, Director, Office of Clinical Trials | Pharmaceutical Drug Directorate | Health Canada (HC)
    • Jennifer Pelley, Director | Office of Legislative and Regulatory Affairs | Health Canada (HC)

    Subject Matter of the communication: Health, Justice and Law Enforcement, Science and Technology, International Trade
    Communication date: 2024-04-30
    Posted date: 2024-05-08
    Communication number: 372370-602195 View associated registration

Public offices held:


Date Modified: